Skip to main content

BGHC.TO

ETF
—
—

Performance overview

BGHC.TO Price
Price Chart

Forward-looking statistics

Beta
0.08
Risk
14.28%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Fund Profile

—

Fund info

—

Investing methodActively Managed
DiversifiedNo
Expense ratio0.75%
Asset classUnknown

Top holdings

Eli Lilly and Co10.36%
UnitedHealth Group Inc9.71%
Novo Nordisk AS Class B6.16%
Thermo Fisher Scientific Inc5.75%
AbbVie Inc5.26%
AstraZeneca PLC4.71%
Elevance Health Inc4.32%
Boston Scientific Corp3.52%
Intuitive Surgical Inc3.45%
Other46.76%

Sector exposure

Healthcare100.00%
Other0.00%

Country exposure

United States75.55%
Denmark7.38%
UK6.31%
Switzerland5.63%
Belgium3.46%
Germany1.62%
Japan0.02%
France0.01%
Australia0.01%
Other0.00%

Company info

Sector—
Industry—
Website—
AUM—

Security info

ExchangeNEO
Type of shareN/A
Earnings per share (EPS)—
Dividend per share—
Revenue per share—
Avg trading volume (30 day)$4K
Avg trading volume (10 day)$1K
Put-call ratioN/A

Macro factor sensitivity

Growth—
Credit—
Liquidity—
Inflation—
Commodities—
Interest Rates—

Upcoming events

Next earnings day—
Next dividend day—
Ex. dividend day—

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free